FATE earnings

Fate Therapeutics (FATE) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.

FATE earnings history

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026Nov 5, 2026-0.25-0.277.45%$0.00
Q2 2026Aug 13, 2026-0.25-0.251.44%$2.08M
Q1 2026May 13, 2026-0.26-0.2910.34%$1.30M
Q4 2025Feb 26, 2026-0.27-0.270.00%$1.37M
Q3 2025Nov 13, 2025-0.27-0.296.90%$1.74M
Q2 2025Aug 12, 2025-0.29-0.3517.14%$1.91M
Q1 2025May 13, 2025-0.32-0.3917.95%$1.63M
Q4 2024Mar 5, 2025-0.44-0.440.00%$1.86M
Q3 2024Nov 12, 2024-0.40––$3.07M
Q2 2024Aug 13, 2024-0.33––$6.77M
Q1 2024May 9, 2024-0.47-0.470.00%$1.93M
Q4 2023Feb 26, 2024-0.45-0.5721.05%$1.68M
Q3 2023Nov 8, 2023-0.46-0.5922.03%$1.94M
Q2 2023Aug 8, 2023-0.54––$933.00K
Q1 2023May 3, 2023-0.19-0.5565.45%$58.98M
Q4 2022Feb 28, 2023-0.58––$44.36M
Q3 2022Nov 3, 2022-0.86-0.937.53%$14.98M